These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9464712)

  • 21. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment.
    St Germain A; Peterson CT; Robinson JG; Alekel DL
    Menopause; 2001; 8(1):17-26. PubMed ID: 11201510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo.
    van de Weijer PH; Barentsen R
    Maturitas; 2002 Jul; 42(3):187-93. PubMed ID: 12161042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J; Graeser T; Mellinger U; Ertan K; Holz C
    Maturitas; 2007 Oct; 58(2):201-7. PubMed ID: 17889463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
    Pinkerton JV; Constantine G; Hwang E; Cheng RF;
    Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate.
    Palacios S; Farias ML; Luebbert H; Gomez G; Yabur JA; Quail DC; Turbi C; Kayath MJ; Almeida MJ; Mönnig E; Nickelsen T
    Am J Obstet Gynecol; 2004 Jul; 191(1):121-31. PubMed ID: 15295352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ospemifene's effect on vasomotor symptoms: a post hoc analysis of phase 2 and 3 clinical data.
    Constantine GD; Archer DF; Pollycove R; Jiang W; Altomare C; Pinkerton JV
    Menopause; 2016 Sep; 23(9):957-64. PubMed ID: 27404027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms.
    Ferrari A
    J Obstet Gynaecol Res; 2009 Dec; 35(6):1083-90. PubMed ID: 20025635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial.
    Buster JE; Koltun WD; Pascual ML; Day WW; Peterson C
    Obstet Gynecol; 2008 Jun; 111(6):1343-51. PubMed ID: 18515518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Lin SQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial.
    Smith LJ; Kalhan R; Wise RA; Sugar EA; Lima JJ; Irvin CG; Dozor AJ; Holbrook JT;
    JAMA; 2015 May; 313(20):2033-43. PubMed ID: 26010632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of acupuncture, applied relaxation, estrogens and placebo on hot flushes in postmenopausal women: an analysis of two prospective, parallel, randomized studies.
    Zaborowska E; Brynhildsen J; Damberg S; Fredriksson M; Lindh-Astrand L; Nedstrand E; Wyon Y; Hammar M
    Climacteric; 2007 Feb; 10(1):38-45. PubMed ID: 17364603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial.
    Carmignani LO; Pedro AO; Costa-Paiva LH; Pinto-Neto AM
    Maturitas; 2010 Nov; 67(3):262-9. PubMed ID: 20833488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H; Al-Azzawi F;
    BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S; Walsh BW; Ciaccia AV; Siddhanti S; Rosen AS; Plouffe L
    Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA;
    Menopause; 2006; 13(2):222-31. PubMed ID: 16645536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial.
    Reddy SY; Warner H; Guttuso T; Messing S; DiGrazio W; Thornburg L; Guzick DS
    Obstet Gynecol; 2006 Jul; 108(1):41-8. PubMed ID: 16816054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance training for hot flushes in postmenopausal women: A randomised controlled trial.
    Berin E; Hammar M; Lindblom H; Lindh-Åstrand L; Rubér M; Spetz Holm AC
    Maturitas; 2019 Aug; 126():55-60. PubMed ID: 31239119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries.
    Penotti M; Fabio E; Modena AB; Rinaldi M; Omodei U; Viganó P
    Fertil Steril; 2003 May; 79(5):1112-7. PubMed ID: 12738504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phytoestrogens for vasomotor menopausal symptoms.
    Lethaby AE; Brown J; Marjoribanks J; Kronenberg F; Roberts H; Eden J
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001395. PubMed ID: 17943751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.
    D'Anna R; Cannata ML; Marini H; Atteritano M; Cancellieri F; Corrado F; Triolo O; Rizzo P; Russo S; Gaudio A; Frisina N; Bitto A; Polito F; Minutoli L; Altavilla D; Adamo EB; Squadrito F
    Menopause; 2009; 16(2):301-6. PubMed ID: 19034051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.